Product Information

RIVASTIGMINE 1.5 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1681 per EA under NDC 62332006360. Its NADAC has been published 223 times since Aug 10, 2022.

FDA first approved this application on Jun 12, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIVASTIGMINE 1.5 MG CAPSULE

Rivastigmine Tartrate
$0.1681per EA

Strength

1.5 mg/1

NDC

62332006360

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

RIVASTIGMINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA091689

FDA Approved

6/12/2012

TE Code

AB

On Market Since

6/12/2022

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for RIVASTIGMINE 1.5 MG CAPSULE has been published 223 times since Aug 10, 2022, and over the history we have for it it has declined 34.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1681 per EA
All-time high$0.2753 (Nov 16, 2022)
All-time low$0.1380 (Nov 22, 2023)
52-week high$0.1693
52-week low$0.1458
Median price$0.1806
Average price$0.1833
Largest weekly change+49.6% (Oct 19, 2022)
Weeks tracked223
Tracking sinceAug 10, 2022

Price History

1W

0.0%

1M

+2.3%

3M

+8.5%

6M

+3.1%

1Y

-9.8%

3Y

-6.4%

5Y

N/A

All

-34.9%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIVASTIGMINE 1.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 1.5 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.1681 per EA (NDC 62332006360), effective Nov 11, 2026.

How has the price of RIVASTIGMINE 1.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has declined 34.9%. It has been tracked across 223 weekly CMS publications since Aug 10, 2022.

What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 1.5 MG CAPSULE?

Since Aug 10, 2022, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has ranged from a low of $0.1380 (Nov 22, 2023) to a high of $0.2753 (Nov 16, 2022), with a median of $0.1806 per EA.

Are there cheaper alternatives to RIVASTIGMINE 1.5 MG CAPSULE?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIVASTIGMINE 1.5 MG CAPSULE, is $0.1508 per EA — about 10% below RIVASTIGMINE 1.5 MG CAPSULE.

Who manufactures RIVASTIGMINE 1.5 MG CAPSULE?

RIVASTIGMINE 1.5 MG CAPSULE (NDC 62332006360) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.